daraxonrasib
Phase 3updated 2mo agoby $RVMD Revolution Medicines, Inc.
Phase 3community read0 votes
indications
indications
NSCLC
all catalysts(1)
phase 1 completion · 1
News(1)
- Revolution drug shows promise in early pancreatic cancer<p>The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.</p>biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that